ALTO Alto Ingredients, Inc.
Industrial Organic Chemicals · Nasdaq · SEC CIK 778164 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.1%
TTM net income YoY201.2%
TTM EPS YoY192.9%
Revenue 3-yr CAGR-9.1%
Net income 3-yr CAGR—
Margins
Gross margin5.8%
Operating margin2.7%
Net margin5.3%
FCF margin3.9%
EBITDA margin5.4%
Returns
ROE20.5%
ROA12.8%
ROIC (approx.)8.6%
Asset turnover2.43x
Leverage & solvency
Liabilities / assets32.1%
Debt / equity0.20x
Current ratio3.39x
Interest coverage3.16x
Cash quality & payout
Operating cash flow / net income1.08x
Accruals ratio-1.1%
Payout ratio—
Capex / revenue1.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $257.88M | $245.70M | $224.68M | $231.97M | $240.99M | $218.44M | $226.54M | $236.35M |
| Cost of revenue | $243.08M | $229.06M | $215.46M | $216.80M | $217.49M | $220.37M | $228.35M | $237.74M |
| Gross profit | $14.80M | $16.64M | $9.22M | $15.16M | $23.49M | -$1.94M | -$1.81M | -$1.39M |
| SG&A expense | $7.79M | $8.02M | $6.70M | $7.33M | $6.51M | $6.17M | $7.19M | $5.33M |
| Operating income | $7.01M | $8.62M | $2.52M | $7.49M | $16.98M | -$8.11M | -$9.00M | -$39.22M |
| Interest expense | $1.52M | $1.96M | $2.20M | $2.42M | $2.80M | $2.81M | $2.73M | $2.47M |
| Pretax income | $13.02M | $11.70M | $4.27M | $21.18M | $14.21M | -$11.00M | -$11.68M | -$41.54M |
| Net income | $13.02M | $11.70M | $4.27M | $21.81M | $14.21M | -$11.00M | -$11.68M | -$41.71M |
| EBITDA | $13.70M | $15.07M | $8.89M | $13.81M | $23.24M | -$1.74M | -$2.73M | -$32.67M |
| EPS (basic) | 0.17 | 0.15 | 0.05 | — | 0.19 | -0.15 | -0.16 | — |
| EPS (diluted) | 0.16 | 0.15 | 0.05 | — | 0.19 | -0.15 | -0.16 | — |
| Weighted avg. shares (diluted) | 77.60M | 77.07M | 76.64M | — | 74.78M | 74.61M | 73.84M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $23.59M | $23.96M | $20.31M | $23.41M | $32.52M | $29.77M | $26.78M | $36.21M |
| Receivables | $64.33M | $67.89M | $59.70M | $55.07M | $54.76M | $57.45M | $65.46M | $58.22M |
| Inventory | $54.31M | $51.61M | $52.83M | $61.68M | $53.39M | $53.87M | $50.61M | $49.91M |
| Current assets | $169.71M | $160.82M | $158.55M | $155.92M | $150.92M | $149.72M | $153.46M | $153.12M |
| PP&E, net | $195.57M | $197.48M | $193.20M | $198.50M | $203.53M | $208.00M | $212.62M | $214.74M |
| Intangibles | $6.89M | $7.26M | $7.42M | $7.57M | $7.73M | $7.88M | $8.14M | $4.51M |
| Total assets | $402.45M | $397.07M | $386.29M | $388.79M | $388.47M | $393.06M | $402.21M | $401.44M |
| Current liabilities | $50.10M | $50.40M | $41.65M | $59.07M | $42.42M | $42.51M | $53.12M | $57.80M |
| Short-term debt | — | — | — | $16.60M | — | — | — | — |
| Long-term debt | $54.47M | $60.47M | $73.06M | $63.03M | $100.60M | $118.32M | $110.66M | $92.90M |
| Total debt | $54.47M | $60.47M | $73.06M | $79.63M | $100.60M | $118.32M | $110.66M | $92.90M |
| Total liabilities | $129.00M | $137.19M | $136.41M | $143.54M | $166.07M | $185.22M | $188.29M | $176.38M |
| Shareholders' equity | $273.45M | $259.88M | $249.88M | $245.24M | $222.40M | $207.84M | $213.92M | $225.06M |
| Net debt | $30.87M | $36.51M | $52.75M | $56.21M | $68.08M | $88.56M | $83.89M | $56.69M |
| Shares outstanding | 77.57M | 77.58M | 77.95M | 77.31M | 77.34M | 77.20M | 76.50M | 76.57M |
| Cash flow statement | ||||||||
| Operating cash flow | $12.87M | $28.48M | $4.21M | $9.54M | $22.78M | -$848,000 | -$18.23M | -$9.79M |
| Capital expenditure | $4.40M | $10.58M | $909,000 | $1.95M | $1.63M | $484,000 | $532,000 | $1.28M |
| Free cash flow | $8.47M | $17.90M | $3.30M | $7.59M | $21.15M | -$1.33M | -$18.76M | -$11.07M |
| Investing cash flow | -$4.40M | -$10.58M | -$909,000 | $4.74M | -$1.63M | -$2.72M | -$7.81M | -$1.28M |
| Financing cash flow | -$6.78M | -$15.58M | -$7.33M | -$21.75M | -$18.50M | $6.89M | $17.00M | $8.79M |
| Depreciation & amortization | $6.69M | $6.45M | $6.37M | $6.33M | $6.26M | $6.37M | $6.27M | $6.55M |
| Stock-based compensation | $908,000 | $813,000 | $705,000 | $842,000 | $706,000 | $626,000 | $848,000 | $707,000 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.